Steroid 5-alpha reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study

Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):417-8.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 3-Oxo-5-alpha-Steroid 4-Dehydrogenase / genetics*
  • Amino Acid Substitution
  • Case-Control Studies
  • Ethnicity
  • Genetic Predisposition to Disease*
  • Humans
  • Male
  • Polymorphism, Genetic*
  • Prostatic Neoplasms / etiology
  • Prostatic Neoplasms / genetics*
  • Registries*
  • Risk Factors

Substances

  • 3-Oxo-5-alpha-Steroid 4-Dehydrogenase